SCHEMBL5160878

SCHEMBL5160878

CN(C)c1ccc(NC(=O)[C@H](CNC(=O)CCC(=O)O)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
MAPT P10636 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALOX15 P16050 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
MCL1 Q07820 1/20 0.47
CRHBP P24387 2/20 0.46
CRHR2 Q13324 2/20 0.46
GAA P10253 2/20 0.45
KMT2A Q03164 3/20 0.44
HDAC3 O15379 4/20 0.44
HDAC4 P56524 4/20 0.44
HDAC1 Q13547 4/20 0.44
HDAC7 Q8WUI4 4/20 0.44
HDAC2 Q92769 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163056 0.93 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5162891 0.87 ALDH1A1 (0.56) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5160150 0.85 MEN1 (0.50) ALDH1A1GAAKMT2AHDAC3HDAC4
SCHEMBL5157981 0.84 ALDH1A1 (0.44) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5157860 0.80 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5158187 0.79 MEN1 (0.48) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL6443377 0.75 CTSK (0.55)
SCHEMBL6407703 0.74 MMP1 (0.53) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL29522596 0.73 ALDH1A1 (0.60) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5160354 0.71 MEN1 (0.59) ALDH1A1MAPTNPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753733-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES Avanir Pharmaceuticals (US) 2007-02-21 EP disclosed
WO-2005123700-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO disclosed